Market Overview:

The alopecia treatment market comprises products used for treating hair loss such as shampoos, conditioners, vitamins and supplements and medical treatments. These products help in inhibiting further hair loss and promoting hair regrowth. Medical treatments such as hair transplants, injections and topical solutions play an important role in regaining hair density and strength in cases of severe hair thinning or baldness.

Market Key Trends:

One of the major trends in the alopecia treatment market is the increasing demand for natural and herbal remedies. Patients are adopting alternative treatments such as application of essential oils, onion juice with water, aloe vera gel and massage with olive or coconut oil as these pose minimal side effects and are easily available. Also, increased R&D investments by market players to develop advanced treatment options have encouraged individuals to treat alopecia at early stages. Some of the novel product in pipelines include SIRPaFc fusion proteins, ROCK inhibitors and prostaglandin inhibitors which are expected to revolutionize alopecia treatment in the future with improved efficacy and reduced outcomes.

Segment Analysis
The global alopecia treatment market is segmented into product type, disease type, sales channel, and region. Based on product type, the market is bifurcated into topical drugs, oral drugs, hair transplant services, low-level laser therapy, and others. Among these, the oral drugs segment accounted for the largest market share in 2022 owing to the high number of prescriptions for oral treatments such as Minoxidil. In terms of disease type, the market is categorized into androgenic alopecia, alopecia areata, cicatricial alopecia, and other alopecia types. Among them, androgenic alopecia held the largest share in 2022 as it is the most common form of hair loss affecting men and women across all age groups.

Key Takeaways

The Global Alopecia Treatment Market Demand is expected to witness high growth, exhibiting CAGR of 5.6% over the forecast period, due to increasing awareness about available treatment options and rising prevalence of alopecia disorders.

Regional analysis – North America dominated the global market in 2022 and is estimated to continue its dominance over the forecast period. This is attributed to the presence of key market players, advanced healthcare infrastructure, and growing research on alopecia treatment in the region. Asia Pacific is expected to witness the fastest growth rate owing to increasing cases of hair fall disorders, rising healthcare expenditure, and growing medical tourism in countries such as India, China, and South Korea.

Key players – Key players operating in the alopecia treatment market are Stemson Therapeutics, OliX Pharmaceuticals, Inc, Pfizer Inc, Aclaris Therapeutics, Inc., Fagron, Follicum AB, Cipla Inc., Arcutis Biotherapeutics, Dr. Reddyâ€TMs Laboratories Ltd., Himalaya Wellness Company, Stemson Therapeutics, Cosmo Pharmaceuticals N.V., Equillium, Inc., Eli Lilly and Company, Concert Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. Stemson Therapeutics and OliX Pharmaceuticals are involved in developing innovative stem cell and nanosome treatments for alopecia which is expected to boost their market share over the forecast period.

Note:

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it